2X0 Stock Chart & Stats
€72.86
€0.00(0.00%)
At close: 4:00 PM EDT
€72.86
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€52.15 - €77.80
Previous CloseN/A
Volume0.00
Average Volume (3M)96.00
Market Cap
€46.14B
Enterprise Value€59.23K
Total Cash (Recent Filing)€2.37B
Total Debt (Recent Filing)€4.88B
Price to Earnings (P/E)53.2
Beta0.30
Next Earnings
Nov 11, 2026EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend Yield0.86%
Share Statistics
EPS (TTM)1.51
Shares Outstanding667,196,000
10 Day Avg. Volume163
30 Day Avg. Volume96
Financial Highlights & Ratios
PEG Ratio1.89
Price to Book (P/B)1.89
Price to Sales (P/S)2.62
P/FCF Ratio16.19
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€82.17Price Target Upside12.78% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)3.29
Revenue Forecast (FY)€15.83B
Bulls Say, Bears Say
Bulls Say
Conservative Balance SheetLow leverage and a large, stable equity base give Corteva financial flexibility to fund research, support seasonal needs, and absorb operating volatility. This capitalization reduces dependence on borrowing and preserves room for disciplined investment or shareholder returns over the next several quarters.
Technology And New-Product PipelineCorteva’s proprietary genetics, crop-protection innovations, and licensing capabilities create differentiated revenue opportunities beyond established products. A growing contribution from new launches and royalties can improve product mix, reinforce farmer adoption, and support durable growth despite mature-market pressure.
Improving Earnings ExecutionStrong first-half execution and higher guidance indicate that productivity actions, pricing and mix, licensing, and commercial performance are translating into better earnings power. The targeted 22.5%–23.5% EBITDA margin also suggests management is building a more sustainable profitability framework.
Bears Say
Weak Recent Revenue TrendThe latest trailing-period contraction shows that Corteva’s broad scale has not recently translated into dependable top-line expansion. Persistent weakness would limit operating leverage, make growth more reliant on launches and mix, and reduce the cushion supporting investment in innovation and market development.
Cash-Flow VolatilityThe substantial decline from 2025 cash generation reduces internally funded flexibility and makes capital allocation more sensitive to working-capital and investment demands. Although TTM free cash flow still covered a meaningful share of earnings, the lower absolute level signals material execution and timing volatility.
Crop-Protection Pricing PressurePricing pressure can erode revenue quality and margins even when product volumes grow, especially where generic alternatives intensify competition. Brazil is a notable exposure, and management’s expectation of no near-term price recovery makes sustained improvement dependent on new products, productivity, and favorable mix.
Corteva News
2X0 FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was €52.15 and its highest was €77.80 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is €46.14B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Nov 11, 2026 which is in 49 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on Jul 30, 2026. The company reported €2.002 earnings per share for the quarter, beating the consensus estimate of €1.947 by €0.056.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of €0.157 which represents an annual dividend yield of 0.86%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is -0.34.
How many shares outstanding does Corteva have?
Corteva has 667,196,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of €2.002 in its last earnings report, beating expectations of €1.947. Following the earnings report the stock price went down -2.33%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in DE:2X0
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€82.17 (12.78% Upside)
€82.17 (12.78% Upside)
Blogger Sentiment
Bullish
DE:2X0 Sentiment 63%
Sector Average 67%
Sector Average 67%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.26%
12-Months-Change
Fundamentals
Return on Equity
0.86%
Trailing 12-Months
Asset Growth
-0.28%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
2X0 Company Deck
2X0 Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call delivered a broadly positive message: strong first-half execution drove revenue, margin and EBITDA gains; management raised full-year guidance and reported meaningful progress on the planned separation with dis-synergies largely mitigated. Notable challenges include crop protection pricing pressure (especially in Brazil), near-term cash flow impacts from one-time items, seasonal Q3 weakness and farmer margin/credit constraints in Latin America. Overall the company emphasized durable technology-led demand, productivity gains, and a healthy new product and licensing pipeline, while acknowledging localized and timing risks.View all DE:2X0 earnings summaries2X0 Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
2X0 Stock 12 Month Forecast
Average Price Target
€82.17
▲(12.78% Upside)